Pardes Financial Statements From 2010 to 2024
| PRDSDelisted Stock | USD 2.14 0.01 0.47% |
Check Pardes Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pardes Biosciences' main balance sheet or income statement drivers, such as , as well as many indicators such as . Pardes financial statements analysis is a perfect complement when working with Pardes Biosciences Valuation or Volatility modules.
Pardes |
Pardes Biosciences Company Return On Equity Analysis
Pardes Biosciences' Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current Pardes Biosciences Return On Equity | -0.4 |
Most of Pardes Biosciences' fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pardes Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
CompetitionBased on the latest financial disclosure, Pardes Biosciences has a Return On Equity of -0.4028. This is 98.32% lower than that of the Biotechnology sector and 98.9% lower than that of the Health Care industry. The return on equity for all United States stocks is 29.94% higher than that of the company.
Pardes Biosciences Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Pardes Biosciences's current stock value. Our valuation model uses many indicators to compare Pardes Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Pardes Biosciences competition to find correlations between indicators driving Pardes Biosciences's intrinsic value. More Info.Pardes Biosciences is regarded fifth in return on equity category among its peers. It is rated below average in return on asset category among its peers . Comparative valuation analysis is a catch-all technique that is used if you cannot value Pardes Biosciences by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.About Pardes Biosciences Financial Statements
Pardes Biosciences shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Pardes Biosciences investors may analyze each financial statement separately, they are all interrelated. The changes in Pardes Biosciences' assets and liabilities, for example, are also reflected in the revenues and expenses on on Pardes Biosciences' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease. The company was incorporated in 2020 and is headquartered in Carlsbad, California. Pardes Biosciences operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 61 people.
Thematic Opportunities
Explore Investment Opportunities
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Consideration for investing in Pardes Stock
If you are still planning to invest in Pardes Biosciences check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Pardes Biosciences' history and understand the potential risks before investing.
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |